Skyrizi 150 MG/ML penml
Ended Awarded Last action
- Contract number
- SPE2DR26F13LM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,467
Award facts
- Contract value 100% obligated
- $12,467.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on December 31, 2025, for SKYRIZI 150 MG/ML in pen-milliliter formulation. The firm fixed-price order, valued at $12,467.00, is scheduled for completion by January 2, 2026, and represents a non-set-aside, competitively awarded contract. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
The award reflects AmerisourceBergen's established role as a critical vendor within the federal medical procurement system, with demonstrated capability to fulfill specialized pharmaceutical needs for the Department of Defense and affiliated healthcare systems. SKYRIZI, a biologic immunosuppressant medication, addresses specific therapeutic requirements within the military healthcare supply chain. The contract structure, including firm fixed pricing and expedited completion timeline, underscores the time-sensitive nature of pharmaceutical delivery to support ongoing military healthcare operations and readiness.
Quick answers
Who was awarded contract SPE2DR26F13LM?
SPE2DR26F13LM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 31, 2025.
How much is contract SPE2DR26F13LM worth?
The government has obligated $12,467 on SPE2DR26F13LM.
Is contract SPE2DR26F13LM an order under another contract?
Yes. SPE2DR26F13LM is a delivery order under SPE2DR25D1110, an indefinite delivery contract.
Was contract SPE2DR26F13LM competed?
The extent of competition for SPE2DR26F13LM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award